Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Accured Expenses: 2018-2025

Historic Change in Accured Expenses for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $2.5 million.

  • Evolus' Change in Accured Expenses rose 16.53% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year decrease of 153.92%. This contributed to the annual value of $7.0 million for FY2024, which is 22.23% down from last year.
  • Latest data reveals that Evolus reported Change in Accured Expenses of $2.5 million as of Q3 2025, which was up 88.26% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Evolus' Change in Accured Expenses peaked at $11.8 million during Q2 2021, and registered a low of -$14.2 million during Q1 2025.
  • Moreover, its 3-year median value for Change in Accured Expenses was $2.2 million (2024), whereas its average is $519,545.
  • Per our database at Business Quant, Evolus' Change in Accured Expenses crashed by 355.53% in 2022 and then soared by 278.36% in 2024.
  • Evolus' Change in Accured Expenses (Quarterly) stood at $6.6 million in 2021, then slumped by 177.61% to -$5.1 million in 2022, then surged by 239.52% to $7.1 million in 2023, then fell by 17.23% to $5.9 million in 2024, then grew by 16.53% to $2.5 million in 2025.
  • Its Change in Accured Expenses stands at $2.5 million for Q3 2025, versus $1.3 million for Q2 2025 and -$14.2 million for Q1 2025.